Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 45,159 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $0.93, for a total transaction of $41,997.87. Following the transaction, the chief executive officer owned 659,644 shares in the company, valued at $613,468.92. This trade represents a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Amit Gupta also recently made the following trade(s):
- On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The stock was sold at an average price of $0.90, for a total transaction of $46,844.10.
- On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total transaction of $6,794.19.
Cardlytics Stock Down 4.8%
NASDAQ:CDLX opened at $0.89 on Friday. The company has a market capitalization of $47.91 million, a price-to-earnings ratio of -0.42, a price-to-earnings-growth ratio of 0.15 and a beta of 1.03. Cardlytics, Inc. has a one year low of $0.80 and a one year high of $3.28. The stock has a 50-day simple moving average of $1.09 and a 200 day simple moving average of $1.40. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on CDLX
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently made changes to their positions in the stock. Invesco Ltd. boosted its position in Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after purchasing an additional 46,973 shares during the period. Barclays PLC increased its position in Cardlytics by 31,167.6% in the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock worth $64,000 after buying an additional 55,790 shares during the period. Renaissance Technologies LLC bought a new stake in Cardlytics in the fourth quarter valued at $62,000. Goldman Sachs Group Inc. lifted its stake in Cardlytics by 15.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after buying an additional 14,273 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Cardlytics by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after acquiring an additional 20,908 shares during the period. 68.10% of the stock is currently owned by institutional investors and hedge funds.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Read More
- Five stocks we like better than Cardlytics
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
